反应 #2446111

反应方程式

Potassium bis(trimethylsilyl)amide

Sodium bicarbonate

DCM trifluoroacetic acid

carbamoyl chloride

Oxycodone

→

oxycodone

N-methyl-N-(2-amino)ethylcarbamate

TFA

溶剂

THF

THF

反应条件

后处理

1. 1
   其他in dry
2. 2
   其他degassed tetrahydrofuran (120 mL)
3. 3
   workup.STIRRINGThe mixture was stirred at −5° C. for 30 min
4. 4
   workup.STIRRINGThe reaction was stirred at room temperature for 2 h
5. 5
   浓缩The mixture was concentrated under vacuum to half of its initial volume
6. 6
   workup.ADDITIONEtOAc (50 mL) was added
7. 7
   其他layers were separated
8. 8
   洗涤The organic phase was further washed with water (3×20 mL) and brine (40 mL)
9. 9
   浓缩was concentrated
10. 10
    其他The residue was purified by silica gel chromatography
11. 11
    其他to afford a white foam in 55% yield (7.0 g, 13.4 mmol)
12. 12
    workup.STIRRINGstirred for 1 h
13. 13
    浓缩The solution was then concentrated under vacuum

实验过程

Oxycodone free base (6.5 g, 20.6 mmol) was dissolved in dry, degassed tetrahydrofuran (120 mL), and the mixture was cooled to −10° C. using a dry ice/acetone bath. Potassium bis(trimethylsilyl)amide (KHMDS) (103.0 mL, 51.6 mmol, 0.5 M in toluene) was added via cannula. The mixture was stirred under N2 at below −5° C. for 30 min. N,N-Bis(tert-butyl) N′-2-(chlorocarbonyl(methyl)amino)ethylcarbamate (8.0 g, 23.7 mmol), (Compound C) in THF (30 mL) was then added via cannula over 15 min. The mixture was stirred at −5° C. for 30 min. Another portion of carbamoyl chloride (4.0 g, 11.9 mmol) in THF (10 mL) was added. The reaction was stirred at room temperature for 2 h. Sodium bicarbonate (10 mL, sat. aq.) was added. The mixture was concentrated under vacuum to half of its initial volume. EtOAc (50 mL) was added, and layers were separated. The organic phase was further washed with water (3×20 mL) and brine (40 mL), and then was concentrated. The residue was purified by silica gel chromatography, using DCM/MeOH (gradient 100/1 to 100/15) to afford a white foam in 55% yield (7.0 g, 13.4 mmol). This material was dissolved in a 1:1 mixture of DCM/trifluoroacetic acid (TFA) (20 mL/20 mL) at room temperature and stirred for 1 h. The solution was then concentrated under vacuum to afford a TFA salt of oxycodone 6-(N-methyl-N-(2-amino)ethylcarbamate (Compound KC-19) as a thick oil (7.3 g, 11.4 mmol, 99% purity). MS: (m/z) calc: 415.2, observed (M+H+) 416.5.

来源